Time- and spatially resolved LNA delivery via thermally controlled SPION technology

Area of Science:

• Biomedical Engineering
• Nanotechnology
• RNA Therapeutics

Background:

• Targeted RNA delivery is crucial for reducing drug dosage and off-target effects.
• Current methods lack precise spatial and temporal control.
• MicroRNA-21 (miRNA-21) is a key regulator in cardiac fibrosis.

Purpose of the Study:

• To develop a novel nanoparticle platform for externally controlled, thermally triggered RNA release.
• To demonstrate organ-specific delivery and on-demand drug release.
• To evaluate the therapeutic potential of this platform in a cardiac fibrosis model.

Main Methods:

• Superparamagnetic iron oxide nanoparticles (SPIONs) conjugated with a thermosensitive linker and locked nucleic acid (LNA).
• Thermosensitive release triggered by external heat, utilizing the tert-butyloxycarbonyl (Boc) group.
• In vitro and in vivo characterization including stability, biocompatibility, biodistribution, toxicology, and therapeutic efficacy in a cardiac fibrosis model.

Main Results:

• The SPION platform demonstrated stability and biocompatibility.
• Efficient, thermally triggered, and traceless release of LNA was achieved.
• Successful in vivo validation showed promising biodistribution, safety, and therapeutic potential in a cardiac fibrosis model targeting miRNA-21.

Conclusions:

• The developed SPION-based platform offers precise spatial and temporal control for RNA therapeutics.
• This technology enables on-demand drug release at target sites, reducing systemic exposure.
• The platform shows broad translational potential for various disease applications requiring targeted RNA delivery.